Eran Hornstein, MD, PhD
Weizmann Institute of Science
Characterizing IL-18 PathwayInhibitors as Therapeutics for ALS
This project aims to test IL-18 receptor function in human C9orf72 models of ALS and to test IL-18 pathway inhibitors as therapeutic for patients with ALS based on recent genetics discoveriesfrom the Hornstein lab at Weizmann Institute of Science.